HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.430
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed

HCW Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
16446983--
Market Cap Growth
-68.58%-35.84%-17.13%---
Enterprise Value
25394943--
Last Close Price
0.431.231.912.32--
PE Ratio
--1.76-4.60-3.39--
PS Ratio
4.0315.5110.22---
PB Ratio
-3.883.271.841.62--
P/FCF Ratio
-1.09-1.53-3.32-7.52--
P/OCF Ratio
-1.36-1.96-6.61-7.55--
EV/Sales Ratio
6.4113.857.31---
EV/EBITDA Ratio
-0.78-1.58-3.39-3.34--
EV/EBIT Ratio
-0.77-1.53-3.26-3.20--
EV/FCF Ratio
-1.28-1.37-2.38-3.88--
Debt / Equity Ratio
-1.590.480.18-0.04-
Debt / FCF Ratio
-0.45-0.22-0.32--0.05-
Asset Turnover
0.120.080.13-0.32-
Quick Ratio
0.080.5910.9915.8710.946.90
Current Ratio
0.100.7311.5217.4412.147.53
Return on Equity (ROE)
-344.32%-98.23%-33.63%-39.22%-49.60%-
Return on Assets (ROA)
-70.09%-42.68%-18.79%-24.25%-28.59%-
Return on Capital (ROIC)
-119.52%-50.27%-19.79%-25.26%-30.38%-
Earnings Yield
-235.90%-56.72%-21.69%-15.52%--
FCF Yield
-137.77%-65.16%-30.08%-13.30%--
Buyback Yield / Dilution
-2.42%-0.30%-90.84%-296.07%-10.56%-
Total Shareholder Return
-2.42%-0.30%-90.84%-296.07%-10.56%-
Source: S&P Capital IQ. Standard template. Financial Sources.